Recombinant Cell Culture Supplements Market Growth Driven by Biopharma Innovations
The recombinant cell culture supplements market is on track to reach US$940 Mn by 2031, rising from US$499 Mn in 2024 at a CAGR of 9%. This growth is driven by increasing demand for biologics, stem cell research, and oncology studies. Recombinant supplements are crucial for supporting healthy cell growth in various therapeutic and research applications. Advancements in recombinant DNA technology continue to enhance scalability, cost efficiency, and innovation in pharmaceutical manufacturing.